Keywords: Myocardium, Low-Field MRI
Motivation: Ferumoxytol-enhanced cardiac MRI has potential to detect ischemia by enabling more accurate and sensitive assessment of changes in myocardial blood volume. However, in-vivo comparison of ferumoxytol behavior at different field strengths is lacking.
Goal(s): To compare the myocardial and blood T1 sensitivity to ferumoxytol and T1 map quality between 0.55T and 3T.
Approach: We analyzed and compared a) relative myocardial and blood T1 changes with different ferumoxytol doses, b) artifact severity at two field strengths
Results: 0.55T demonstrated 2.5-fold greater myocardial T1 sensitivity to ferumoxytol compared to 3T, with significantly reduced susceptibility artifacts.
Impact: The increased ferumoxytol sensitivity at 0.55T enables potential dose reduction while maintaining diagnostic quality, offering a more robust platform for MBV assessment. This could particularly benefit stress/rest T1 reactivity measurements where detecting subtle MBV changes is crucial.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords